Stock events for HCA Healthcare, Inc. (HCA)
HCA Healthcare's stock price has experienced fluctuations in the past six months. Over the last 12 months, the stock's price increased, but it has seen a year-to-date decrease and a decrease in the past month as of May 9, 2026. Recent events impacting the stock include the company's first-quarter 2026 results, which were met with a negative market reaction due to a milder respiratory season and the impact of a severe winter storm. Policy headwinds, including Medicaid and ACA subsidy rollbacks, are also expected to temper growth in the coming years.
Demand Seasonality affecting HCA Healthcare, Inc.’s stock price
HCA Healthcare experiences demand seasonality for its products and services, particularly with a typical increase in patient volumes during the first quarter due to the winter flu season. However, in Q1 2026, the company did not experience this typical seasonal lift, as respiratory-related admissions and emergency room visits significantly declined due to a milder respiratory season and a major winter storm.
Overview of HCA Healthcare, Inc.’s business
HCA Healthcare, Inc. is an American for-profit operator of healthcare facilities founded in 1968 and headquartered in Nashville, Tennessee. It operates in the healthcare sector, primarily in the hospital and ambulatory surgery center industries, offering a range of services including hospital, ambulatory, and physician services, as well as medical research and education.
HCA’s Geographic footprint
HCA Healthcare operates approximately 190 hospitals and around 2,500 ambulatory sites of care across 20 states in the United States and in the United Kingdom. The company has a strong presence in Florida and Texas, with these two states accounting for more than half of HCA's hospitals in the U.S. Other states with a notable HCA presence include Tennessee, Virginia, and Colorado.
HCA Corporate Image Assessment
HCA Healthcare has maintained a strong brand reputation, receiving several notable recognitions. HCA Healthcare was named on Fortune's 2025 World's Most Admired Companies list, ranking first overall in its industry for the 12th consecutive year. The company was also recognized on Fortune's America's Most Innovative Companies list. HCA Healthcare has also been involved in community initiatives, such as deploying colleagues to disaster areas and contributing to community organizations for hurricane relief. The company also conducts an annual prescription drug take-back day and contributes to community organizations.
Ownership
Institutional investors hold a substantial portion of HCA Healthcare's stock, approximately 91% by early 2026. The largest institutional shareholders include The Vanguard Group, BlackRock, and State Street. The Frist family, who founded HCA Healthcare, remains an influential insider holder through trusts and entities linked to Dr. Thomas F. Frist Jr.
Ask Our Expert AI Analyst
Price Chart
$404.69